HuGE Literature Finder
Records
1
-
4
TET2, DNMT3A, IDH1, and JAK2 Mutation in Myeloproliferative Neoplasms in southern Iran. International journal of organ transplantation medicine 2022 5 12 (3): 12-20. Abedi E, Ramzi M, Karimi M, Yaghobi R, Mohammadi H, Bayat E, Moghadam M, Farokhian F, Dehghani M, Golafshan H A, Haghpanah |
The role of new technologies in myeloproliferative neoplasms: Application of next-generation sequencing in myelofibrosis. International journal of laboratory hematology 2021 3 43 (5): 1070-1077. Navrátilová Jana, Palová Miroslava, Szotkowski Tomáš, Hluší Antonín, Katrincsáková Beáta, Papajík Tomáš, Indrák Kar |
Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms. Blood 2016 Jun . Hinds David A, Barnholt Kimberly E, Mesa Ruben A, Kiefer Amy K, Do Chuong B, Eriksson Nicholas, Mountain Joanna L, Francke Uta, Tung Joyce Y, Nguyen Huong Marie, Zhang Haiyu, Gojenola Linda, Zehnder James L, Gotlib Jas |
Frequency of heterozygous TET2 deletions in myeloproliferative neoplasms. Cancer management and research 2010 12 2 219-23. Tripodi Joseph, Hoffman Ronald, Najfeld Vesna, Weinberg Ro |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: